A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Completed

• Conditions: Immune Thrombocytopenia

• Registration Number: NCT01974232
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

This is a retrospective analysis of children (≤21years old) who received clinical treatment with either Romiplostim or Eltrombopag at 2 medical centers from 2009-2013. The children included in this study were from Weill Medical College of Cornell University, New York, New York and Children's Hospital Orange County, Orange, California

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2012-01
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Study First Submitted: 2013-10-25
• Study First Submitted QC: 2013-10-25
• Study First Posted: 2013-11-01
• Status Verified: 2017-01
• Last Update Submitted: 2017-01-30
• Last Update Posted: 2017-02-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

1. All patients in this study had received prior treatments before the start of TPO treatment including corticosteroids, IVIG, IV anti-D, and/or Rituximab.

Read More

Exclusion Criteria

1. Children who do not have ITP

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Platelet count greater than or = to 50,000	on two consecutive weeks

Secondary Outcome Measures

Name	Time	Method
An increase in platelets greater than or = to 20,000 over baseline.	On two consecutive weeks

Trial Locations

Locations (1)

Weill Cornell Medical College; 🇺🇸 New York, New York, United States